As of 30 Sep 2025, 84 institutional investors reported holding 10,315,270 shares of GALECTIN THERAPEUTICS INC - COM NEW (GALT).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 170,234 | $683,170 | +$9,997 | $4.16 | 8 |
| 2025 Q3 | 10,315,270 | $43,896,766 | -$59,971 | $4.24 | 84 |
| 2025 Q2 | 10,463,242 | $22,085,893 | +$1,798,912 | $2.11 | 84 |
| 2025 Q1 | 9,907,188 | $12,120,102 | -$167,181 | $1.22 | 88 |
| 2024 Q4 | 10,110,015 | $13,012,103 | -$70,473 | $1.29 | 94 |
| 2024 Q3 | 9,746,940 | $26,802,293 | +$625,575 | $2.75 | 78 |
| 2024 Q2 | 9,417,077 | $21,280,501 | +$4,010,257 | $2.26 | 71 |
| 2024 Q1 | 7,591,787 | $18,144,362 | +$1,149,883 | $2.39 | 57 |
| 2023 Q4 | 7,221,573 | $11,998,463 | -$3,154,063 | $1.66 | 66 |
| 2023 Q3 | 9,051,475 | $17,375,764 | +$3,461,982 | $1.92 | 59 |
| 2023 Q2 | 7,271,442 | $10,470,025 | +$114,381 | $1.44 | 58 |
| 2023 Q1 | 7,155,735 | $15,019,803 | +$222,174 | $2.10 | 55 |
| 2022 Q4 | 7,105,475 | $8,031,212 | +$165,111 | $1.13 | 58 |
| 2022 Q3 | 6,925,544 | $11,283,983 | -$167,283 | $1.63 | 51 |
| 2022 Q2 | 7,046,893 | $9,228,368 | -$579,530 | $1.31 | 53 |
| 2022 Q1 | 7,459,376 | $12,001,681 | -$281,390 | $1.61 | 53 |
| 2021 Q4 | 7,325,883 | $15,165,161 | -$499,136 | $2.07 | 52 |
| 2021 Q3 | 7,287,350 | $28,239,646 | -$2,237,797 | $3.88 | 66 |
| 2021 Q2 | 7,893,506 | $25,251,481 | -$5,902,902 | $3.20 | 70 |
| 2021 Q1 | 9,406,177 | $20,414,792 | -$1,888,720 | $2.17 | 68 |
| 2020 Q4 | 10,768,536 | $23,988,956 | +$1,272,225 | $2.24 | 74 |
| 2020 Q3 | 10,045,218 | $26,830,365 | -$333,937 | $2.67 | 67 |
| 2020 Q2 | 10,161,248 | $31,077,126 | +$1,533,958 | $3.06 | 73 |
| 2020 Q1 | 9,676,162 | $18,961,521 | -$1,077,308 | $1.96 | 72 |
| 2019 Q4 | 10,063,446 | $28,783,662 | +$1,845,277 | $2.86 | 75 |
| 2019 Q3 | 9,386,211 | $34,438,974 | +$3,018,308 | $3.67 | 75 |
| 2019 Q2 | 8,481,799 | $35,182,714 | +$4,361,160 | $4.15 | 71 |
| 2019 Q1 | 7,300,056 | $37,300,204 | +$9,156,802 | $5.11 | 62 |
| 2018 Q4 | 5,731,512 | $19,686,137 | -$2,548,068 | $3.43 | 57 |
| 2018 Q3 | 6,014,860 | $36,148,300 | +$2,413,240 | $6.01 | 58 |
| 2018 Q2 | 5,574,695 | $35,452,254 | +$4,184,678 | $6.36 | 66 |
| 2018 Q1 | 4,979,115 | $23,594,190 | +$6,247,048 | $4.74 | 57 |
| 2017 Q4 | 3,732,462 | $12,473,134 | -$430,534 | $3.34 | 45 |
| 2017 Q3 | 3,888,235 | $8,295,086 | -$6,442 | $2.13 | 45 |
| 2017 Q2 | 3,831,156 | $9,418,000 | +$860,773 | $2.46 | 44 |
| 2017 Q1 | 3,625,185 | $8,336,000 | +$2,110,920 | $2.30 | 39 |
| 2016 Q4 | 2,848,806 | $2,787,000 | -$227,562 | $0.98 | 35 |
| 2016 Q3 | 3,032,931 | $3,425,775 | -$602,452 | $1.13 | 41 |
| 2016 Q2 | 3,500,347 | $5,142,675 | -$566,403 | $1.47 | 44 |
| 2016 Q1 | 3,488,141 | $4,983,000 | -$242,724 | $1.43 | 41 |
| 2015 Q4 | 3,586,091 | $5,871,000 | +$1,284,078 | $1.64 | 49 |
| 2015 Q3 | 2,652,972 | $7,015,000 | -$1,738,505 | $2.34 | 41 |
| 2015 Q2 | 3,325,529 | $9,074,596 | -$2,104,345 | $2.73 | 52 |
| 2015 Q1 | 4,048,478 | $13,570,527 | +$950,442 | $3.35 | 56 |
| 2014 Q4 | 3,758,562 | $13,036,775 | -$3,098,185 | $3.47 | 58 |
| 2014 Q3 | 4,279,131 | $21,526,740 | -$4,779,569 | $5.03 | 60 |
| 2014 Q2 | 4,244,719 | $58,616,737 | +$8,957,096 | $13.81 | 61 |
| 2014 Q1 | 3,468,577 | $53,101,000 | +$31,889,795 | $15.31 | 49 |